Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today ...
CARMEL, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical ...
The Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts ...
Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing of its initial public offering of 1,500,000 ...
An Omani state-run oil and gas company says it will make an initial public offering of its exploration and production ...
Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company") (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics ...
New York, NY, Sept. 17, 2024 (GLOBE NEWSWIRE) -- YHN Acquisition I Limited (the "Company") announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The units ...
BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters will have a 30-day option to purchase an additional ...
Newsmax Inc. is pleased to announce that it has confidentially filed with the Securities and Exchange Commission (“SEC”) an offering statement and expects to conduct an initial public offering ...
Andretti Acquisition Corp. II is a special purpose acquisition company (often called a blank-check company), or SPAC, formed ...
In addition, Zenas has granted the underwriters a 30-day option to purchase up to an additional 1,985,294 shares of common stock at the initial public offering price, less underwriting discounts ...